Description
Cinnarizin (Cinnarizinum) forte 0.075 №20
Composition
Active ingredient: Cinnarizine 75mg per tablet.
Mechanism of Action
Cinnarizine, the active ingredient in Cinnarizin forte 0.075 №20, is a calcium channel blocker with antihistaminic properties. It improves cerebral blood flow and reduces the sensitivity of the vestibular system, thereby alleviating symptoms of vertigo and motion sickness.
Pharmacological Properties
Cinnarizine acts by blocking calcium channels and histamine receptors, leading to vasodilation and decreased excitability of the inner ear structures. It exerts antiemetic and antivertigo effects through its action on the vestibular system.
Indications for Use
Cinnarizin forte 0.075 №20 is indicated for the treatment of vertigo, motion sickness, and symptoms of Meniere’s disease.
Contraindications
Do not use Cinnarizin forte 0.075 №20 if you are allergic to cinnarizine or any other ingredients in the product. It is important to consult a healthcare professional before starting this medication.
Side Effects
Common side effects of Cinnarizin forte 0.075 №20 may include drowsiness, dry mouth, and gastrointestinal disturbances. It is advisable to avoid driving or operating heavy machinery until the effects of the medication are known.
Usage Instructions
Take one tablet daily with a glass of water, preferably after a meal to minimize the risk of stomach upset. Follow the dosage recommended by your healthcare provider.
Benefits Compared to Analogues
Cinnarizin forte 0.075 №20 offers effective relief from vertigo, motion sickness, and Meniere’s disease symptoms with a well-established safety profile. Its unique mechanism of action provides targeted symptom relief without significant sedative effects.
Suitable Patient Groups
This medication is suitable for use in adults, including the elderly population, for the management of vertigo and related conditions. It is not recommended for use in children without medical supervision.
Storage and Shelf Life
Store Cinnarizin forte 0.075 №20 in a cool, dry place away from direct sunlight. Check the expiration date on the packaging and do not use the product after the specified date.
Packaging Description
Cinnarizin forte 0.075 №20 is available in a package containing 20 tablets. Each tablet is film-coated for easy swallowing and protection of the active ingredient.
Clinical Evidence and Proven Effectiveness
Several studies have demonstrated the efficacy of cinnarizine in managing vertigo and Meniere’s disease. A study published in the journal Clinical Otolaryngology showed that cinnarizine significantly reduced the frequency and severity of vertigo attacks in patients with Meniere’s disease.
